News Focus
News Focus
icon url

zj3001

09/10/16 9:26 AM

#3647 RE: tjguy #3644

Isn't the fda approval based on safety of use and proof the product effectively has proof to it's claim? Not sure how you get won't approve two products slapped together.
icon url

TradeFlow

09/10/16 11:19 AM

#3652 RE: tjguy #3644

Respectfully disagree. With a few ex-FDA guys on their team (why would people who know the process jump on board if they didn't think it would be given a green light), plus positive P3 efficacy it's a matter of time IMO.
icon url

scottsmith

09/10/16 3:00 PM

#3654 RE: tjguy #3644

Do you think they've already shown some additional efficacy or not yet?
icon url

TrumpsVP

09/10/16 8:47 PM

#3662 RE: tjguy #3644

Do yourself a favor and do more research. The compound effects are synergistic, the one pill will be cheaper than the two, the pain med is a reminder to take the commonly forgotten hyper-t med, it's easier, and it's patented.

40% of doctors said they would prescribe this over Celebrex.

Dude, don't miss out on this life changing opportunity.
icon url

TrumpsVP

09/10/16 8:49 PM

#3663 RE: tjguy #3644

"They will need to show some extra efficacy of some kind for a more certain win"

That is exactly what they did. The effective reduction of hyper-t was greater than with amlodipine alone.

SYNERGY